Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A.H.L. Low
OP0208 a Proof-Of-Concept Double-Blind Randomised Placebo-Controlled Trial of Probiotics in Systemic Sclerosis Associated Gastrointestinal Disease
Related publications
Neprilysin Inhibition for Pulmonary Arterial Hypertension: A Randomized, Double-Blind, Placebo-Controlled, Proof-Of-Concept Trial
British Journal of Pharmacology
Pharmacology
A Randomized Double-Blind Placebo-Controlled Trial of Probiotics in Post-Surgical Colorectal Cancer
BMC Gastroenterology
Medicine
Gastroenterology
A Selective Neurokinin-1 Receptor Antagonist in Chronic PTSD: A Randomized, Double-Blind, Placebo-Controlled, Proof-Of-Concept Trial
European Neuropsychopharmacology
Psychiatry
Mental Health
Neurology
Biological Psychiatry
Pharmacology
Adjuvant Imatinib Mesylate After Resection of Localised, Primary Gastrointestinal Stromal Tumour: A Randomised, Double-Blind, Placebo-Controlled Trial
The Lancet
Medicine
CCR5 Blockade in Rheumatoid Arthritis: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Randomised, Double-Blind, Placebo-Controlled Trial of EPs 7630 in Adults With COPD
Respiratory Medicine
Pulmonary
Respiratory Medicine
Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
Limited Effect of Sulphasalazine Treatment in Reactive Arthritis. A Randomised Double Blind Placebo Controlled Trial
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
TRYMS: The Ethical and Practical Considerations of a Double-Blind Placebo Controlled Randomised Clinical Trial
Trials
Medicine
Pharmacology
